| Product Name | Vedolizumab |
|---|---|
| CAS | 943609-66-3 |
| Appearance | Colorless to light yellow (Solution) |
| Storage condition | Sealed and Store at -80°C. Aliquots should be stored at the same temperature after first use to avoid freeze-thaw cycles |
| Size | Availability | Price(USD) | VIP Price (USD) | Quantity |
|---|---|---|---|---|
| 1 mg | 3-5days | $600.00 | Visible after login | |
| 5 mg | 3-5days | $1600.00 | Visible after login | |
| 10 mg | 3-5days | $2800.00 | Visible after login | |
| 50 mg | 3-5days | $13000.00 | Visible after login | |
| 100 mg | 3-5days | $20000.00 | Visible after login |
| Product Name | Vedolizumab |
|---|---|
| CAS | 943609-66-3 |
| Appearance | Colorless to light yellow (Solution) |
| Storage condition | Sealed and Store at -80°C. Aliquots should be stored at the same temperature after first use to avoid freeze-thaw cycles |
Vedolizumab (anti-α4β7-integrin) is a humanized IgG1 monoclonal antibody that targets the α4β7 integrin for the treatment of ulcerative colitis and Crohn's disease.